Table of contents

Editorial

Meet the team
Bengt Winblad, MD, Ph.D., Professor
Original Contribution/Clinical Investigation
Review articles

 

Epilepsy in aged people: an introduction to diagnosis and treatment

Authors
Mojtaba Azimian, MD Asghar Dadkhah, PhD.
University of Welfare and Rehabilitation Science



Abstract:

Old age is the most common time in life to develop epilepsy. Diagnosis and treatment of disease in elderly people needs special capabilities. There is no exception for epilepsy in this regard. According to research a high incidence of convulsion in aged people is increasing. Average life expectancy at birth has increased by 20 years since 1950, to 66 years and is expected to extend a further 10 years by mid-century.

This demographic triumph means that the number of older people will increase from about 600 million in 2000 to almost 2,000 million in 2050. The provision of both health and social care to older people is a necessity.

Incidence of epilepsy in the elderly (over 80 years old) is 140 in 100,000. Diagnosis of this disease is so important in old age people because problems such as Transient Ischaemic Attack (T.I.A), cardiovascular problems, and transient confusion in patients with dementia, neurogenic syncope, and Transient Global Amnesia (TGA), can mimic or be feigned by it. Sometimes the picture of symptoms is different between young and older persons; and may even appear as non-convulsive status epilepticus (NCSE). On the other hand, senile changes that cause epilepsy in elderly must be subject to further studies.

Treatment and selection of drugs in elderly people needs special consideration. Different changes such as metabolic changes, changes in brain tolerance to drugs and side effects, changes in function of bodily organs, associated diseases and consumption of various drugs at the same time, provide many challenges during the treatment process. The knowledge regarding the importance of epilepsy in elderly is increasing. Nowadays, senile affairs and the problem of elderly people is regarded seriously and consequently there is hope that in the near future the knowledge and understanding about effective factors regarding epilepsy in old age persons, such as senile changes of brain and its effect on epilepsy, will be expanded and increase.

Key Words: Epilepsy; Elderly; Diagnosis; Treatment.



Introduction

Average life expectancy at birth has increased by 20 years since 1950, to 66 years, and is expected to extend a further 10 years by mid-century. This demographic triumph means that the number of older people will increase from about 600 million in 2000 to almost 2,000 million in 2050. The provision of both health and social care to older people is a truth.

Nowadays, through use of health/treatment interventions and expansion of science, the age of people in societies has been increased. Due to the increase of age, diseases of this population will have special importance. Old age is the most common time in life to develop epilepsy. Making a secure diagnosis can be difficult, and piecing together an accurate picture of events may take some time. Neurological diseases have a special place among different diseases in elderly. Epilepsy is one of these diseases that may be developed in this age for the first time, or had been prolonged from previous years to this special senile condition. Epilepsy, besides physical effects, can cause severe psychological impacts in elderly people, and in some ways, affect quality of life. There are reports that incidence of epilepsy, for the first time, in this age range, is increasing (Bergey, 1994). After initial incidence in the first years of life, for a few decades, the incidence up to 65 years of age will be stable. After 65 years of age, abruptly, the incidence of epilepsy will be increased (Hauser , 1992).

Due to organic factors, some of which are indicated below, epilepsy in elderly people can appear as a primary or secondary condition:

1) Metabolic disorders such as hyperglycemia, hypoglycemia , hyponatremia , uremia , hypocalcemia.
2) Sudden interruption of drugs like barbiturates and benzodiazepines.
3) Intaking of drugs which increase the risk of incidence of epilepsy such as phenotiazins , tri-cyclic antidepressants , theophylline , antibiotics.
4) Infections : meningitis , pneumonia , urinary infection.
5) Trauma
6) Cerebrovascular Accident (CVA)
7) Dementia
8) Neoplasm

Primary or idiopathic epilepsy make approximately 50% of epilepsy in old age people. Incidence of epilepsy in elderly, in different studies, have been mentioned 100-140 per 10/0000 (Hauser,et al,1993). In one study the incidence of acute convulsion (for the first time) in the age more than 65 years, have been depicted 24-30 % (Sanders,et al, 1990). Also, 30% of convulsion in elderly people have status convulsion, which is twice of this condition in lower ages (Towne, et al, 1994). Status convulsion is so important in emergency cases in neurology science.


Diagnosis of epilepsy in elderly people

Because epilepsy in old-age persons can mimic other diseases, its diagnosis is difficult. Unfortunately, in most cases the diagnosis is not correct. Fortunately, nowadays, knowledge in this regard has increased and medical/ therapeutic personnel have more information and research on the topic.

The primary evaluation of epileptic persons is the same as for other ages. A precise history must be taken from the patient and his/her family. Exact questions regarding type of seizures and risk factors such as head trauma (hard or soft) should be asked. The incidence of complex partial epilepsy in old ages is higher and after 60 years of age the rate of incidence, is abruptly increased. This is in contrast with the young ages, that is, the generalized, tonic-colonic epilepsy has the highest rate of incidence. On the other hand, it is confirmed that the postictal condition in elderly people differs from young people. This condition is longer in older persons and sometimes its duration is a few days or even many weeks and, mostly presents as loss of memory, behavioural disorder, aphasia or motor (movement) disorder. Incidence of epilepsy with non-specific signs in the elderly, is so important:

1) One of these signs is behavioral disorder which is produced intermittently, especially when it is accompanied by cognitive disorders. Sometimes patients are referred with symptoms of dementia, and because the incidence of it is high in old-ages, the diagnosis of epilepsy may be missed.
2) Neurogenic syncope: On the whole, diagnosis of neurologic syncope is not problematic. With case history, and assessment of postictal condition, the type of epilepsy can be differentiated.
3) Cardiac diseases include: intermittent arrhythmia such as atrial fibrillation (AF), supra-ventricular tachycardia, Stoke Adams attack can result in syncope. Sometimes syncope is followed by convulsions. After treatment of cardiac disease, the syncope will be treated.
4) Vascular diseases of the brain such as T.I.A: In this case accompanying of other neurologic signs like hemiparesis, hemiplegia, hemisensory or parastesis could be assigned as a diagnosis of TIA. In cases with motor signs the diagnosis is simple but if the sensory signs exist on their own, diagnosis of epilepsy will be difficult (Penfield et al, 1959). In these cases, EEG especially can be helpful and in 10% of cases, will be positive (Devinsky, et al, 1988).
5) Drop-attack: In this condition the patient may fall abruptly immediately after standing and sometimes drops objects. Sometimes, falling itself causes injuries.
6) Epileptic aphasia: one of the problem in the diagnosis of epilepsy in T.I.A is the epileptic aphasia; especially in patients with the history of C.V.A., at least once(Rosenbaum et al,1986). The process of producing aphasia can help us to differentiate it from T.I.A. In epileptic aphasia there is no neurological sign. EEG is helpful in this regard.
7) T.G.A: Beginning of memory loss is abrupt in these diseases and short term memory is mostly affected. In T.G.A the patient asks the same questions sequentially. The average time for one T.G.A is 7-9 hours (Caplan,et al,1985). During the attack, EEG is normal (Gloor, in press). Generally, it is presents onece in a lifetime, but sometimes it happens more than once.
8) NCSE: these attacks are present as mild confusion amnesia, or severe loss of consciousness. Sometimes it is prolonged, for hours, days or months. The main cause of NCSE is the cessation of Benzodiazepines, so the history of drug consumption can be helpful. EEG is also useful. Opiate consumption can produce and cause NCSE and delay the diagnosis of epilepsy for a long time.

 


Para clinical affairs

Because the toxic and metabolic aspects are the main and common causes of epilepsy, each patient who has epilepsy for the first time, must be evaluated for cell blood count (CBC), Biochemical tests such an electrolytes, calcium and liver and kidney tests. One of the important tests is EEG which must be performed.

EEG is helpful in the diagnosis of disease and type of epilepsy. In elderly people, there is a change in EEG which is not considered as epilepsy. These changes are: slowing and decreasing of EEG voltage especially if these changes are of the diffuse type.

CT-Scans and Magnetic Resonance Imaging (MRI) are the remaining tests for elderly people with a history of the first (or one) epileptic attack. These are helpful in diagnosis of brain vascular and tumoral problems, which are a common cause of epilepsy in elderly persons.

Assessment of cerebrospinalfluid (C.S.F) is helpful, especially when epilepsy is associated with fever or whenever there is suspicion of the presence of meningitis.


Treatment

The main goal of treatment is prevention of epileptic attack recurring. So, whenever there is any reason for recurrent epilepsy, therapeutics must be commenced. Pateints with epilepsy with clear and exact symptoms, such as disturbance in electrolyte concentration, need to take anti-convulsive drugs so that resumption of seizures can be avoided.

According to several factors the probability of epilepsy may be predicted in elderly people with :
1) Movement problems after attack (postictal paralysis)
2) Partial seizure
3) Family history
4) Abnormal EEG
5) Abnormal neurologic examination.

All of these factors contrinute to an increased incidence of epilepsy in such patients.

In elderly people, due to the changes in all systems of the body, drug consumption should be considered carefully; such as:

1) Digestive system: Mucous atrophy in this system due to the changes in serum levels and drug uptake.
2) Kidney function: function of kidney is decreased after 20 years of age and at 80 years old is halved. So, drugs which are exhausted by the kidney may be increased at the serum.
3) Liver function: lack of liver function declines and drugs which are metabolized in liver, consequently the serum level of this drug is increased.
4) Increases of lymph tissues in elderly people cause changes in serum levels.
5) Albumin serum decrease: drugs which are bond with albumin (like phenytoin, valporate sodium) show toxicity symptoms sooner.
6) Increase of half life of drugs in elderly people.
7) Brain atrophy and, consequently, production of further sleepy status is aqffected by anti-convulsive drugs.

Drug application
Today there is a vast variety of drugs for treatment of epilepsy in elderly people, especially since 1993 and with the introduction of a new generation of anticonvulsive drugs, new possibilities have been supported. Among various old drugs, carbamazepin, alone or with valporate sodium, provides first step (frontline) treatment. Among the newer drugs, gabapentin and lamotrigine have special importance and the consumption of tiagabine and topiramate is increasing.

Carbamazepin
Carbamazepin is well tolerated by old age persons. It has low side effects. Despite phenytoin it has no great fluctuation in serum levels. According to the physiologic condition of elderly people, consumption of it during 24 hour must be twice only. It is mainly used in partial epilepsy.

Valporate
Valporate has been used for more than 20 years. In comparison with carbamazepin and phenytoin it has a more effective spectrum, and sois useful in primary tonic-colonic epilepsy treatment. It is also useful in secondary generalized epilepsy (Mattson, et al, 1992). Considering its short half life, this drug should be delivered in several doses. Its main side effects are: tremor, weight increase, hair loss.

Gabapentin
Gabapentin is useful in partial epilepsy, and causes increase in gamma aminobutyric acid (GABA) levels of the brain. It has a 9 hour half life and must be used three times per day. It does not case any change in the outflow of urine, and has no great side effect and can be tolerated well by elderly people.

Lamotrigine
Lamotrigine acts as a glutamate neurotransmitter; and is metabolized by the liver. 10% of it, is discarded by urine. It is useful in treatment of partial epilepsy. It has a 24 hour half life, so, must be used in two doses.

Topiramate
Topiranate is used to assist in treatment of partial epilepsy. It has a 24 hour half life and must be used in two doses; it has low side effects and can be tolerated by elderly people. The main outflow for it, is via the kidney.

Tiagabine
Specifically, Tiagabine inhibits reuptake of GABA and increases its concentration in the brain. It is useful in treatment of partial epilepsy. It is metabolized in the liver. It has a nine hour half life and must be used with different doses.



References

1. Bergey,GK.(2004). Initial treatment of epilepsy: special issues in treating the elderly. Neurology.; 63 (supple 4):s 40-s48.
2. Caplan,LR.(1985). Transient global amnesia. In: vinken PJ, Bruyn GW, Klawans H, eds. Hand book of clinical neurology. Amsterdam: Elsevier Science publishing: 205-18.
3. Devinsky O,Kelley K, Porter RJ, Theodore WH,(1988).clinical and electroencephalographic features of simple partial seizures. Neurology; 38: 1374-52.
4. Gloor p. The EEG during transient global amnesia. Electroencephalogr clin Neurophysiol; in press.
5. Hauser WA, (1992). Seizure disorders: The changes with age. Epilepsia; (Suppl 4) 33:56-514.
6. Hauser WA, Annegers JF, Kurland LT, (1993). The incidence of epilepsy and unprovocked seizures in Rochester, Minnesota, 1935-1984. Epilepsia; 34:453-68.
7. Mattson RH, Cramer JA, Collins JF and the VA Epilepsy cooperative study NO. 264 Group, (1992). A Compareison of Valproate with Carbamazepine for the treatment of partial seizures and secondarily generalized tonic- clonic seizures in adults NEngl J Med;327:765-710.
8. Penfield W, Jasper H, (1959). Epilepsy and the functional anatomy of the brain. Boston: Little Brown:269-70.
9. Rosenbaum DH, Siegel M, Barr WB, Rowan RJ,(1986). Epileptic aphasia. Neurology; 36: 40.
10. Sanders JWA, Hart YM, Johnson AL, et al,(1990). Natural general practice study of epilepsy: newly diagnosed epileptic seizures in general population. Lancet; 336: 1236-1270.
11. Tallis R, (1997).Antiepileptic drug trials in the elderly. Rationale, problems and solution. In: Rowan AJ, Ramsay RE,eds. Seizures and epilepsy in the elderly. Boston: Butterworth. Heinemann:311-20.
12. Towne AR, pelleck JM, Ko D, Delorenzo RJ, (1994). Determinats of mortality in status epilepticus.
Epilepsia;5: 27-34.
13. Tuniper P, (1997).The altered presentation of seizures in the elderly. In: Rowan AJ, Ramsay RE, eds. Seizures and epilepsy in the elderly. Boston: Butterworth. Heinemann: 123-30.